Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

$1.27M GRANT FOR TAXOL STUDY

Oct. 25, 1991

S.R. ONE EXERCISES RIBI WARRANTS

Oct. 25, 1991

PATENT FLASH !

Oct. 25, 1991

IVAX CANCELS NOVEN ACQUISITION

Oct. 25, 1991

REPLIGEN STAGGERS AFTER SPLIT WITH MERCK

Oct. 24, 1991

FDA APPROVES GROWTH DRUG

Oct. 24, 1991

XOMA-CENTOCOR DISPUTE GOES TO JURY

Oct. 24, 1991

AMBISOME BOOSTS VESTAR TO PROFITABLE QUARTER

Oct. 24, 1991

AGOURON COMPLETES 2 MILLION-SHARE OFFERING

Oct. 24, 1991

INTERFERON SCIENCES RAISES $8.5 MILLION

Oct. 24, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...